In India, surgical volume continues to rise, driven by both an expanding population and increasing access to healthcare. In parallel, the utilization of sealant hemostats and adhesives in surgeries has witnessed a notable surge, attributed to their efficacy in controlling bleeding and sealing tissues, thereby reducing complications, and improving patient outcomes. This trend underscores the growing adoption of advanced surgical techniques and the pursuit of enhanced surgical precision and patient safety within the Indian medical landscape.

The focus of this newsletter is to delve more into the Surgical sealants, adhesives, and hemostats market in India and how 1Lattice can provide better insights and support MedTech and Healthcare organizations with key market trends, propelling factors, Government policies, and their impact on the industry.

In India, surgical volume is a critical indicator of healthcare accessibility and demand. The surgical volume reflects the sheer scale of medical interventions required across various specialties, ranging from routine procedures to complex surgeries. Approximately 2.0 Cr specialized surgeries are performed in India annually, 30% of all the surgeries are general surgery followed by gynaecological surgeries (22%). More than half of these are performed in T6 and N20 cities.

Accounting for approximately 6% of the overall APAC market, the sealant, adhesives, and hemostats (SAH) market in India was valued at US$ 30M in 2023 and is anticipated to grow to $64 million by 2029, reflecting a CAGR of around 13%. Within this market, sealants represent over 50% of the total SAH market share in India.

The SAH market is predominantly segmented by product types and end-user demographics. Among product categories, Sealants account for 50% of the market's revenues, while hospitals constitute the primary stakeholder group within the end-user segment.

Key factors contributing to the growth of the Indian sealant, adhesives, and hemostats market include the increasing prevalence of chronic diseases requiring surgical interventions, the rising number of surgical procedures, advancements in medical technology, growing investments in healthcare infrastructure, rising awareness among healthcare professionals regarding the benefits of these products, and supportive government initiatives aimed at improving healthcare access and quality. Additionally, the expansion of medical tourism and the emergence of new applications for sealants, adhesives, and hemostats further bolster market growth prospects in India.

Major barriers to the growth and expansion of the market include regulatory complexities and compliance challenges, price sensitivity among healthcare facilities, and limited reimbursement and insurance coverage. Additionally, infrastructure constraints, such as inadequate storage and distribution networks, can hinder market penetration and access.

Prominent trends shaping the market landscape entail heightened demand for cutting-edge products propelled by the expanding surgical landscape, increased uptake of advanced biomaterials and minimally invasive surgical methodologies, and endeavors in regulatory harmonization aimed at easing market entry for manufacturers, guaranteeing product integrity and effectiveness, and encouraging compatibility among healthcare systems, thereby nurturing innovation and facilitating overall market expansion.

With the 1Lattice 1nsights comprehensive benchmarking suite, we can map and assess the overall Sealant, Adhesive, and Hemostats market in India. Our data-driven approach & robust methodology allow Healthcare and MedTech organizations to make informed decisions about potential segments, market access, competitive landscape benchmarking, and engagement strategies.

 At 1Lattice, our clients stay ahead of the competition. Our multitude of offerings allows companies to win.??